🔎 Trials Near Me

Akèy › Sipwa › Texas › Dallas

Etid klinik pou Sipwa nan Dallas, TX

20 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 2
  • Velocity Clinical Research - Dallas /ID# 282734, Dallas
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07752979

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Ap rekriteFaz 3
  • UT Southwestern Med Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07533175

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Ap rekriteFaz 3
  • North Texas Endocrine Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Ap rekriteFaz 3
  • UT Southwestern Med Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Ap rekriteFaz 3
  • Cedar Health Research - Texas Native Health, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07794579

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Ap rekriteFaz 3
  • Velocity Clinical Research, Dallas, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Ap rekriteFaz 3
  • UT Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07392190

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3
  • Thyroid Endocrinology and Diabetes, Dallas
  • Soltero Cardiovascular Research Center, Dallas
  • Zenos Clinical Research, Dallas
  • ak 2 plis
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Ap rekriteFaz 3
  • Velocity Clinical Research, Dallas, Dallas
  • UT Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • FutureSearch Trials of Dallas, Dallas
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589608

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Ap rekriteFaz 3
  • Velocity Clinical Research, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Ap rekriteFaz 3
  • University of Texas Southwestern Medical Center - Children's Medical Center Dallas, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351045

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Ap rekriteFaz 3
  • Cedar Health Research, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07770841

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • Velocity Clinical Research, Dallas, Dallas
  • FutureSearch Trials of Dallas, Dallas
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Ap rekriteFaz 2
  • Mercy Family Clinic, Dallas
  • Velocity Clinical Research, Dallas, Dallas
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT07215559

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Ap rekriteFaz 3
  • Cedar Health Research, LLC, Dallas
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684235

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Ap rekriteFaz 3
  • Mercy Family Clinic, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07509307

Comparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program

Ap rekrite
  • University of Texas Southwestern, Children's Health, Dallas
Laj 6 a 14 · Tout sèks · Mizajou Mar 30, 2026 · NCT07342855

Healthy Living BEYOND Weight Study

Ap rekriteEtid obsèvasyon
  • American Heart Association, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2025 · NCT07075341

Etid Sipwa nan lòt vil

Lòt etid nan Dallas

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.